These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models]. Author: Xiang QQ, Yang Z, Huai J, Wang GJ. Journal: Zhonghua Fu Chan Ke Za Zhi; 2019 Sep 25; 54(9):601-607. PubMed ID: 31550776. Abstract: Objective: To explore the pathways of preeclampsia by investigating different effects of pravastatin (Pra) on and soluble FMS tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF) and vascular endothelial growth factor (VEGF) in different preeclampsia (PE)-like mouse models. Methods: C57BL/6J mice were randomly subcutaneously injected with N-nitro-L-arginine methyl ester (L-NAME) or intraperitoneally injected with lipopolysaccharide (LPS) as PE-like mouse model, saline as normal pregnancy control (Con) respectively, daily at gestational 7-18 days. Pra was given daily at gestational 8-18 days in each model group and the mice were divided into Pra (L-NAME+Pra, LPS+Pra, Con+Pra) and saline (L-NAME+NS, LPS+NS, Con+NS) groups. Liver,placental tissue and blood of pregnant mice were collected on the 18th day of pregnancy. The levels of VEGF, PlGF and sFlt-1 in the liver, placenta and serum of mice in each group were compared by western blot, ELISA and real-time fluorescence quantitative PCR (RT-PCR). Results: (1) ELISA: Serum VEGF (205.70±3.43, 154.60±2.31) and PlGF (131.5±3.75, 101.50±4.31) levels were significantly increased in L-NAME+Pra group compared with L-NAME+NS group (all P<0.05). Serum VEGF (202.30±4.90, 144.50±6.71) and PlGF (121.50±3.86, 95.41±4.08) levels were significantly higher in LPS+Pra group than those in LPS+NS group (all P<0.05). Serum sFlt-1 level in LPS+Pra group was significantly lower than that in LPS+NS group (3.01±0.50, 776.60±80.06), serum sFlt-1 level in L-NAME+Pra group was significantly lower than that in L-NAME+NS group (2.60±0.06, 583.70±9.83; all P<0.05). (2) Western blot: the expression levels of PlGF (1.344±0.118, 0.664±0.143) and VEGF (1.34±0.12, 0.66±0.14) in the liver of mice in the L-NAME+Pra group were significantly higher than those in the L-NAME+NS group (all P<0.05), but the expression levels of PlGF and VEGF in the placenta of L-NAME+Pra group were not significantly different from those of L-NAME+NS group (all P>0.05). The expression levels of PlGF and VEGF in placenta and liver of pregnant mice in LPS+Pra group were not significantly different from those in LPS+N group (all P>0.05). (3) RT-PCR: the mRNA expression of PlGF and VEGF in placenta and liver of L-NAME+Pra group were not significantly different from those in L-NAME+NS group (all P>0.05). The mRNA expression levels of PlGF and VEGF in placenta and liver of LPS+Pra group were not significantly different from those of LPS+NS group (all P>0.05). Conclusions: Pra has different regulatory effects on vascular endothelial function in different PE-like models. It reveals that different pathogenesis and pathways exist in different PE-like changes. 目的: 研究不同子痫前期(PE)样模型小鼠中普伐他汀(Pra)对可溶性血管内皮生长因子受体1(sFlt-1)、胎盘生长因子(PlGF)、血管内皮生长因子(VEGF)的不同作用。 方法: 采用C57BL/6J小鼠皮下注射亚硝基左旋精氨酸甲酯(L-NAME)或腹腔内注射脂多糖(LPS)建立2种PE样小鼠模型,同期注射生理盐水为正常对照;再分别于妊娠第8天始每天Pra灌胃(L-NAME+Pra组、LPS+Pra组、正常+Pra组)或生理盐水灌胃(L-NAME+生理盐水组、LPS+生理盐水组、正常+生理盐水组)。于妊娠第18天时收集6组孕鼠的肝脏、胎盘组织及血液,通过ELISA、蛋白印迹法、实时荧光定量PCR技术,比较sFlt-1、PlGF及VEGF在各组孕鼠肝脏、胎盘组织及血清中的表达情况。 结果: (1)ELISA的结果:L-NAME+Pra组孕鼠血清中VEGF[分别为205.70±3.43、154.60±2.31]、PlGF[分别为131.50±3.75、101.50±4.31]的水平较L-NAME+生理盐水组均明显上升(P均<0.05);LPS+Pra组孕鼠血清中VEGF[分别为202.30±4.90、144.50±6.71]、PlGF[分别为121.50±3.86、95.41±4.08]的水平较LPS+生理盐水组均明显上升(P均<0.05)。LPS+Pra组孕鼠较LPS+生理盐水组、L-NAME+Pra组孕鼠较L-NAME+生理盐水组的血清sFlt-1[分别为3.01±0.50、776.60±80.06;2.60±0.06、583.70±9.83],水平分别比较,均明显下降(P均<0.05)。(2)蛋白印迹法结果:L-NAME+Pra组孕鼠的肝脏组织PlGF[分别为1.34±0.12、0.66±0.14]、VEGF[分别为1.34±0.12、0.66±0.14]蛋白的表达水平均明显高于L-NAME+生理盐水组(P均<0.05);L-NAME+Pra组孕鼠胎盘的PlGF和VEGF蛋白表达水平与L-NAME+生理盐水组比较,差异均无统计学意义(P均>0.05);LPS+Pra组孕鼠的胎盘及肝脏组织的PlGF、VEGF蛋白的表达水平与LPS+生理盐水组比较,差异均无统计学意义(P均>0.05)。(3)实时荧光定量PCR技术结果:L-NAME+Pra组孕鼠胎盘及肝脏组织中的PlGF mRNA、VEGF mRNA的表达水平与L-NAME+生理盐水组比较,差异均无统计学意义(P均>0.05);LPS+Pra组孕鼠胎盘及肝脏组织的PlGF mRNA及VEGF mRNA的表达水平分别与LPS+生理盐水组比较,差异均无统计学意义(P均>0.05)。 结论: Pra对不同PE模型样小鼠的血管内皮功能有不同的调节作用,不同的PE样变化存在不同的发病机制和通路。.[Abstract] [Full Text] [Related] [New Search]